CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The purpose of this study is to evaluate dexpramipexole as an add-on oral therapy in participants with inadequately controlled eosinophilic asthma...
Phase 3
Hawthorne, New York, United States and 117 other locations
To asses effectiveness and safety of tezepelumab in adult and adolescent participants with severe asthma including several under-studied pop...
Phase 4
New Haven, Connecticut, United States and 44 other locations
and safety of Atuliflapon administered once daily over a 12-week treatment period to adult participants with moderate to severe uncontrolled asthma...
Phase 2
Valhalla, New York, United States and 350 other locations
of clinically significant exacerbations in participants with severe asthma with an eosinophilic phenotype. Throughout the study, all partici...
Phase 3
New Haven, Connecticut, United States and 429 other locations
variable length study to evaluate the efficacy and safety of budesonide/glycopyrronium/formoterol inhaler in adults and adolescents with severe asthma...
Phase 3
Port Jefferson, New York, United States and 444 other locations
variable length study to evaluate the efficacy and safety of budesonide/glycopyrronium/formoterol inhaler in adults and adolescents with severe asthma...
Phase 3
Waterbury, Connecticut, United States and 477 other locations
The purpose of the study is to evaluate effect of benralizumab on structural and lung function changes in severe eosinophilic asthmatics.Changes will...
Phase 4
Port Jefferson Station, New York, United States and 43 other locations
This study will evaluate the efficacy and safety of depemokimab (GSK3511294) in participants with CRSwNP.
Phase 3
New Haven, Connecticut, United States and 84 other locations
This is a randomized, double-blind, placebo-controlled, parallel-group, international, multicenter, Phase 3 study to evaluate the efficacy and safety...
Phase 3
White Plains, New York, United States and 115 other locations
Clinical trials
Research sites
Resources
Legal